Videos
Press Releases
29 Jun 2021
PRESS RELEASE: European Organisation for Research and Treatment of Cancer (EORTC) and Pierre Fabre Partner to Address Treatment Gap for Stage 2 Melanoma Patients
4 Jun 2021
PRESS RELEASE: Sanofi partnering with leading academic cooperative groups to study amcenestrant in the adjuvant setting for patients with estrogen receptor positive breast cancer
20 Apr 2021
PRESS RELEASE: HSH Prince Albert II cedes Honorary Presidency of the EORTC Research Fund to HRH Princess Dina Mired
17 Feb 2021
PRESS RELEASE: Generating recommendations for the design, analysis and interpretation of patient- reported outcome (PRO) data for cancer clinical trials: the launch of SISAQOL-IMI
Latest Newsletter
News
2 May 2025
Important new results from EORTC presented at ESTRO Congress 2025
1 Apr 2025
Brain Tumour Group,Breast Cancer Group,Cutaneous Lymphoma Tumours Group,Diagnostic and Therapeutic Imaging,Endocrine Tumours Group,Gastrointestinal Tract Cancer Group,Genito-Urinary Cancers Group,Gynecological Cancer Group,Head and Neck Cancer Group,Leukemia Group,Lung Cancer Group,Lymphoma Group,Melanoma Group,News,Older Adults Council,Pathobiology Group,Pharmacology & Molecular Mechanisms Group,Quality of Life Group
New study confirms link between cancer patients’ quality of life and survival
17 Mar 2025
New Treatment for Recurrent Meningioma: LUMEN-1 Clinical Trial
6 Feb 2025
SISAQOL-IMI consortium launches final recommendations
4 Feb 2025
World Cancer Day 2025: EORTC’s commitment to older patients
11 Dec 2024
EORTC and Immunocore announce enrolment of first patient onto the only active Phase 3 adjuvant trial in uveal melanoma
21 Nov 2024
Minister F. Vandenbroucke visits EORTC Headquarters to strengthen collaborative efforts in clinical cancer research
5 Nov 2024
EORTC SPRINT clinical cancer study receives support from Rising Tide Foundation to reduce the burden for patients
29 Oct 2024
Pink October at EORTC: Over 60 years of impactful breast cancer research
